Loïc Roux, Founder of OligoTune Ltd: Tackling Undruggable Targets with New Modalities
Dr Roux discusses the importance of synthesizing, characterizing and purifying new modalities, and describes the evolving landscape in finding solutions for patients with undruggable diseases.